» Articles » PMID: 6208924

Inhibition of the Recovery from Potentially Lethal Damage by Lonidamine

Overview
Journal Br J Cancer
Specialty Oncology
Date 1984 Nov 1
PMID 6208924
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Lonidamine [1-(2,4-dichlorobenzyl)-1-H-indazol-3-carboxylic acid] is shown to inhibit recovery from potentially lethal damage after exposure of cells to X-rays, methyl methane sulfonate, or bleomycin and heat (43 degrees C, 1h). Inhibition is most effective when the drug is present before and after exposure of 10 to 25 mg l-1, a concentration readily achievable in vivo.

Citing Articles

Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy.

Orlovskiy S, Gupta P, Roman J, Arias-Mendoza F, Nelson D, Koch C Cancers (Basel). 2024; 16(7).

PMID: 38611062 PMC: 11010960. DOI: 10.3390/cancers16071384.


The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.

Huang Y, Sun G, Sun X, Li F, Zhao L, Zhong R Cancers (Basel). 2020; 12(11).

PMID: 33187214 PMC: 7696079. DOI: 10.3390/cancers12113332.


Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma.

Cruz-Gregorio A, Martinez-Ramirez I, Pedraza-Chaverri J, Lizano M Cancers (Basel). 2019; 11(2).

PMID: 30764513 PMC: 6406552. DOI: 10.3390/cancers11020182.


Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.

Lyons J, Song C, Ross B J Neurooncol. 1998; 36(2):149-57.

PMID: 9525814 DOI: 10.1023/a:1005819604858.


Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.

De Cesare M, Pratesi G, Giusti A, Polizzi D, Zunino F Br J Cancer. 1998; 77(3):434-9.

PMID: 9472640 PMC: 2151278. DOI: 10.1038/bjc.1998.69.


References
1.
Phillips R, Tolmach L . Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res. 1966; 29(3):413-32. View

2.
Hahn G, Little J . Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. Curr Top Radiat Res Q. 1972; 8(1):39-43. View

3.
Evans R, Bagshaw M, Gordon L, Kurkjian S, Hahn G . Modification of recovery from potentially lethal x-ray damage in plateau phase Chinese hamster cells. Radiat Res. 1974; 59(3):597-605. View

4.
Braun J, Hahn G . Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res. 1975; 35(11 Pt 1):2921-7. View

5.
Twentyman P, Bleehen N . Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. Br J Cancer. 1975; 32(4):491-501. PMC: 2024758. DOI: 10.1038/bjc.1975.251. View